Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors. - Wikidata - wikimedia - TriplyDB

Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors.

Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors.

http://www.wikidata.org/entity/Q37132720

about

Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas Adoptive T-cell therapy for cancer: The era of engineered T cells Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): study protocol for a phase II study.TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host Disease Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.Immunotherapeutic Intervention against Sarcomas.Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy.Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumors Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses.Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.Targets of tumor immunity after allogeneic hematopoietic stem cell transplantation.Preimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation.Review of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in solid tumors excluding breast cancer.The allogeneic graft-versus-cancer effect.Current immunotherapy for solid tumors.Is adoptive T-cell therapy for solid tumors coming of age?The graft-versus-neuroblastoma effect of allogeneic hematopoietic stem cell transplantation, a review of clinical and experimental evidence and a perspective on mechanisms.Adoptive immunotherapy against sarcomas.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Recipient leukocyte infusion enhances the local and systemic graft-versus-neuroblastoma effect of allogeneic bone marrow transplantation in mice.A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations.Treating breast cancer with cell-based approaches: an overview.Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial.HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer.Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation.Tumor rejection effects of allorestricted tumor peptide-specific CD4(+) T cells on human cervical cancer cell xenograft in nude mice.Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma.Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire.Melanoma in patients with GATA2 deficiency.Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras.A Review of Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Breast Cancer Reduced-intensity allografting in patients with therapy-related myeloid neoplasms and active primary malignancies Tumors with a more complex genome have a higher frequency of HLA class I total loss: a unifying pan-cancer hypothesis

P2860

Q24234049-50FC4630-767A-4C11-8C61-C0724CB14CA4 Q26800611-396A6455-D555-4436-8FA2-E037AE475C7C Q33559203-E6FAF682-A78D-4A68-8B19-406195B9E428 Q33835099-7C553A78-C54A-4291-982F-6279DB59686C Q33842493-480D3F50-6AAF-4DFA-B10D-72448DFA0D05 Q34196481-4FA51C0B-F287-4FA1-A1BE-E365B4910911 Q34426965-D75CF871-3ED3-42DE-BD8E-89659B275EBA Q35683306-D6BBDC16-007A-4FDE-BEB8-FBB788B3E6B0 Q36398704-6C132529-99AE-4F4F-98F4-4C8976C9881D Q36994811-5C462762-1B37-4531-8971-DE4E1B4A34A1 Q37002020-D4EEE42F-E542-4EBD-A239-BC7AD584F4E5 Q37242262-DE44A09B-1435-405F-A571-B24766169206 Q37482548-923E6D44-73A6-4C71-87F3-33482A439213 Q37522583-D7217889-C904-4192-ABC6-F43F71FE68F5 Q37593125-BC456B91-ABE3-4D93-9F40-755C2B1523FA Q37773274-A192EC57-767D-4D93-AE27-3B0063C8505C Q37909004-511F61B8-DA2D-4B36-8975-1ECBBC07D0C5 Q38243215-4E4E1AF1-F52E-4EEA-B363-BC25A16905CD Q38291193-45A2AC59-D0F9-483B-808E-E01AA4A3E954 Q38387292-21CFF1BB-6E12-43E7-A1F0-B61E41F537B4 Q39089535-6BB51E92-A5E2-4931-B118-DE17C167EAB2 Q39157279-265340DA-FABC-4D99-A6B7-D3A14CB22CA6 Q39448180-822CA62D-E827-430C-92F5-B0867FBD469D Q39877306-F07C04FF-E10A-4518-8F56-E6C5C5F2B1F4 Q39960197-6F540AFE-AAC6-4C7D-87A4-73836779D818 Q40093716-BE22021E-CC8F-4FD3-9E96-CEB05899C2AA Q41577518-1F14269D-91B7-402F-9E00-363906B8DF64 Q44473706-30C4AB85-C768-4C1F-867A-AE96715300FE Q45874368-4959D63D-0903-4D69-8BCB-4958038A8DB1 Q46120530-C83E8CC3-760A-499A-AA2D-25CC8B60D17A Q48270523-B5A5D469-9542-49F2-B85E-6BC4721C4E6A Q48312537-AB7BA7A0-C960-47EE-9BF6-F409798C1855 Q57113963-35C7838C-0473-4CB3-9F5C-4F6AFD554A54 Q57636771-5C0E47FE-0AF9-4FBE-8AE3-03A2963A1602 Q58050251-FAC2E7D3-A060-44D2-A6A8-C31DDB8542FF

P2860

Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors.

http://www.wikidata.org/entity/Q37132720

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Transplantation of allogeneic ...... ent modality for solid tumors.

@en

Transplantation of allogeneic ...... ent modality for solid tumors.

@nl

type

label

Transplantation of allogeneic ...... ent modality for solid tumors.

@en

Transplantation of allogeneic ...... ent modality for solid tumors.

@nl

prefLabel

Transplantation of allogeneic ...... ent modality for solid tumors.

@en

Transplantation of allogeneic ...... ent modality for solid tumors.

@nl

P1433

Q37132720-18F19A60-20B8-4651-ADCF-4926C8878E99

P1476

Q37132720-B64FDEFF-F48D-4CEF-A5A0-FE266F97FF73

P2093

Q37132720-03B866BC-EF85-4B43-8EE3-2273C6F43BDE

Q37132720-1ECD80EF-BDBA-47F5-8496-B4C81A709ADA

Q37132720-300D6322-29C5-488B-9DFF-CBB785C38F51

Q37132720-416C0CB4-7568-495E-999B-6DD347B0E680

Q37132720-5AAB07A9-8CC1-4E5E-80E6-1B3846717AE4

Q37132720-81652215-A3E1-49E6-8F5E-F0CEC171EFD1

Q37132720-83B24358-1255-45D6-B8F4-4DD1860FF02E

Q37132720-B4DE4151-40BC-47CF-874F-7081F1905C8E

Q37132720-BBA25F14-4474-40AC-91A7-B6DEB3916B7D

Q37132720-C7507D33-968F-41C8-8B06-D88061D710CE

P2888

Q37132720-38902683-E8DA-4FEA-9997-FDA3E20920AB

P304

Q37132720-6D257A9A-9E0C-4927-8077-4333B83273B2

P31

Q37132720-BF57BC11-58C8-4DAD-93D0-FD5A2BF14757

P356

Q37132720-12555DAC-F9CE-4528-9ADC-6D8A2993157A

P433

Q37132720-8E9E55A9-5223-4092-9646-E56C4D9EE11E

P478

Q37132720-5806EED9-BEDA-4D68-B4C6-F9D96317BA09

P50

Q37132720-3A6B4A7E-05FF-43F5-845E-1D767EA1DD18

P577

Q37132720-06525F65-5AC5-4A55-A203-1C4BAF149224

P6179

Q37132720-3C43A09E-D0C2-4FF1-859C-BC0CFD713085

P698

Q37132720-8C7AA05C-11E0-4892-99FA-4509BF0AD2CE

P356

P1433

Nature Clinical Practice Oncology

P1476

Transplantation of allogeneic ...... ent modality for solid tumors.

@en

P2093

Angelo Michele Carella

http://www.w3.org/2001/XMLSchema#string

Didier Blaise

http://www.w3.org/2001/XMLSchema#string

Dietger Niederwieser

http://www.w3.org/2001/XMLSchema#string

EBMT Solid Tumors Working Party

http://www.w3.org/2001/XMLSchema#string

Fikret Arpaci

http://www.w3.org/2001/XMLSchema#string

Giovanni Rosti

http://www.w3.org/2001/XMLSchema#string

Gunhan Gurman

http://www.w3.org/2001/XMLSchema#string

Lisbeth Barkholt

http://www.w3.org/2001/XMLSchema#string

Marco Bregni

http://www.w3.org/2001/XMLSchema#string

Massimo Aglietta

http://www.w3.org/2001/XMLSchema#string

P2888

P304

256-267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPONC1104

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Jacques-Olivier Bay

P577

2008-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010410430

http://www.w3.org/2001/XMLSchema#string

P698

18398414

http://www.w3.org/2001/XMLSchema#string